A new report indicates that U.S. drugmakers will raise prices on at least 350 medications despite pressure from President ...
Connecticut data from 2022 to 2023 show medications from retail pharmacies accounted for the state's highest health care ...
A little-known Cigna Group subsidiary that sells generic drugs charges prices that skew higher than many competing suppliers, according to a new analysis that raises questions about the company’s role ...
Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...
Nov 12 (Reuters) - Plaintiffs in a sweeping antitrust case over generic drug pricing have asked a federal judge to intervene against a group of claims recovery firms they say are misleading class ...
A federal judge in Pennsylvania has approved a nearly $60 million settlement with a trio of drug makers who are defendants in a multi-district litigation claiming numerous companies fixed the prices ...
Indian pharmaceutical exports, including generic drugs, are unlikely to be affected by US President Donald Trump's recent announcement of 100 per cent tariffs on “any branded or patented" drugs ...
Oct 31 (Reuters) - A federal judge on Friday said 36 drugmakers and executives must face nearly all claims in an antitrust lawsuit brought by most U.S. states, accusing them of conspiring to fix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results